Bionano Genomics, Inc. (BNGO) News

Bionano Genomics, Inc. (BNGO): $1.98

0.13 (+6.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BNGO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Filter BNGO News Items

BNGO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BNGO News Highlights

  • BNGO's 30 day story count now stands at 28.
  • Over the past 19 days, the trend for BNGO's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
  • The most mentioned tickers in articles about BNGO are NVDA, SP and BASE.

Latest BNGO News From Around the Web

Below are the latest news stories about BIONANO GENOMICS INC that investors may wish to consider to help them evaluate BNGO as an investment opportunity.

Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies

SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the launch of OGM-Dx™ HemeOne™, a laboratory developed test (LDT) based on optical genome mapping (OGM) analysis of blood or bone marrow samples to detect structural variants (SVs) of diagnostic and prognostic utility in individuals with a new or an existing diagnosis of a hematological malignancy. Compared to traditional cytogenetic methods, this OGM-based assay offers a streamlined and improved workflow to assess

Yahoo | January 24, 2023

Watch this stock’s price performance: Bionano Genomics Inc. (NASDAQ:BNGO)

Currently, Bionano Genomics Inc.’s (BNGO) stock is trading at $1.92, marking a gain of 5.19% from last night’s close. At this price, the stock is -55.75% below its 52-week high of $4.35 and 65.95% above its 52-week low of $1.16. Based on the past 30-day period, the stock price is -4.29% below the high and […]

US Post News | January 23, 2023

Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow

Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughputBionano Prep Direct Label and Stain-G2 (DLS-G2) kit offers increased reagent stability and labeling efficiency resulting in significantly faster sample to results workflowSaphyr Chip® G3.3, instrument control software (ICS) version 5.3 and Bionano Access™ software version 1.7.2 offer enhanced evaporation control and workflow robustness enabling for more high coverage samples to be run per

Yahoo | January 23, 2023

3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street

When the curtain closed on 2022, the ageless Dow Jones Industrial Average, widely followed S&P 500, and growth-dependent Nasdaq Composite, respectively finished lower by 9%, 19%, and 33%. It was, collectively, the worst performance for Wall Street in 14 years. This is why most analyst price targets point to upside in equities.

Yahoo | January 23, 2023

After Bionano Genomics Inc. (NASDAQ: BNGO) Surges -605.88% From Highs, What Will It Look Like?

During the last session, Bionano Genomics Inc. (NASDAQ:BNGO)’s traded shares were 6.34 million, with the beta value of the company hitting 2.26. At the end of the trading day, the stock’s price was $1.70, reflecting an intraday loss of -7.10% or -$0.13. The 52-week high for the BNGO share is $4.35, that puts it down … After Bionano Genomics Inc. (NASDAQ: BNGO) Surges -605.88% From Highs, What Will It Look Like? Read More »

Marketing Sentinel | January 20, 2023

Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM Presentations and Live Panel Discussions Across a Wide Range of Genetic Disease and Cancer Research Applications

27 different customers representing North America and Europe30 oral presentations across four consecutive days34 scientific posters will be featured in a virtual exhibition hallTopics span the application of optical genome mapping (OGM) in genetic disease, cancer research and cell bioprocessing SAN DIEGO, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its Symposium 2023 lineup of 30 oral presentations delivered from 27 different customers worldwide featur

Yahoo | January 20, 2023

7 Must-Buy Nasdaq Stocks to Kick Off the First Quarter

With the Nasdaq Composite having risen a robust 6% in the first two weeks of the New Year, it appears that the exchange, in line with my previous predictions, is well on its way to entering a bull market. Further, recent developments, including strong holiday-season retail sales growth and a month-over-month drop in December’s Consumer Price Index, indicate that the Street’s fears about the macro environment last year were tremendously overdone. Also worth noting is that, with institutional inve

Yahoo | January 18, 2023

Bionano Announces Publication of Interim Readout from Clinical Trial Run by Consortium Analyzing Optical Genome Mapping as Potential Standard of Care for Prenatal Testing

IRB-approved, multi-site, ongoing study evaluated 200 samples representing 123 unique prenatal cases across 9 sites for interim measures of key endpoints: Results of OGM analysis were comparable, in a single assay, to the results of two separate standard of care (SOC) tests needed to reach a diagnosis in 56% of cases (69/123) and to three separate SOC tests needed to reach a diagnosis in 19% of cases (23/123)Concordance with SOC for all calls – 100% [200 out of 200 samples]Concordance with SOC f

Yahoo | January 18, 2023

Bionano to Accelerate Data Processing Solution for Optical Genome Mapping Workflow with NVIDIA

SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a collaboration with NVIDIA to develop an acceleration platform for use in Bionano’s optical genome mapping (OGM) workflow. This collaboration is expected to significantly improve data processing speed while reducing time and cost associated with secondary analysis of OGM data. The computation platform is designed to enable a small laboratory and information technology footprint, which would allow for rapid decentralized deployment.

GlobeNewswire | January 12, 2023

Bionano, Nvidia collaborate on data processing solution for genome mapping tool

Bionano Genomics (BNGO) is collaborating with Nvidia (NVDA) to develop an acceleration platform for use in Bionano''s optical genome mapping ((OGM)) workflow.The collaboration is…

Seeking Alpha | January 12, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 2.5789 seconds.